A Simple Clinical Tool for Increasing Enrollment on a Kidney Transplant Waiting List for Patients Aged Over 70 and Initiating Dialysis

NCT ID: NCT02746146

Last Updated: 2021-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-05

Study Completion Date

2020-03-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to show that the systematic use of a prognostic score as early as possible after the initiation of dialysis in patients over 70 years of age and with a good prognosis at 3 years of dialysis results in an increase in the number of entries on a kidney transplant waiting list at 12 months after the initiation of dialysis.

This prospective assessment is carried out as part of a historico-prospective before-after study in parallel with a survey of changes in national practices over the same time period via a here-elsewhere type study.

Historical data (i.e the. "before" period) will include incident dialysis cases during the calendar years 2013, 2014 and 2015 before the start of the prospective phase (i.e. "after" period, which is represented by the current declaration); since a preliminary study demonstrated that the data are comparable from 2011 to 2013, we will use the average of data thus obtained. Historical data will be retrieved from the REIN (The French Renal Epidemiology and Information Network) registry data and will be validated by investigators at each center.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The secondary objectives are:

A. To show that the systematic use of the score at the initiation of dialysis can shorten the registration delay on a kidney transplant waiting list; to evaluate the time between initiation of dialysis and registration on a national waiting list for kidney transplants, while assessing the duration of the pre-transplant assessment.

B. To identify barriers to registration on the kidney transplant waiting list as well as the related time delay in this population (medical and non-medical factors), the rates and causes of patient refusal for registration and the possible evolution this refusal over time.

C. To evaluate the economic impact of the introduction of the renal transplant clinical prognostic score.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Failure, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic dialysis patients

The study population consists of patients over 70 (≥) and under 85 years (\<) of age with stage 5 chronic renal disease and initiating a first session of chronic dialysis in the Languedoc-Roussillon and Midi-Pyrénées regions. Eligible patients must have a 3 year prognostic mortality score less than (\<) 7 points (Dusseux et al. 2015).

Intervention: Systematic use of a prognostic score

Group Type EXPERIMENTAL

Systematic use of a prognostic score

Intervention Type OTHER

The prognostic score is given in Dusseux et al 2015. It will be used as soon as possible after the initiation of dialysis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Systematic use of a prognostic score

The prognostic score is given in Dusseux et al 2015. It will be used as soon as possible after the initiation of dialysis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 12 months of follow-up
* Patient initiating chronic dialysis (incident cases)
* Patients with a 3 year prognostic mortality score less than (\<) 10 points (Dusseux et al. 2015)

Exclusion Criteria

* The patient is participating in another interventional study
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* Patient on preemptive kidney transplant waiting list (before the initiation of a chronic dialysis program)
Minimum Eligible Age

70 Years

Maximum Eligible Age

84 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier Moranne, MD, PhD

Role: STUDY_DIRECTOR

Centre Hospitalier Universitaire de Nîmes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Claude Bernard

Albi, , France

Site Status

AIDER - Unité de Dialyse d'Alès

Alès, , France

Site Status

CH d'Auch

Auch, , France

Site Status

Centre d'Hemodialyse Languedoc Méditérranéen

Béziers, , France

Site Status

Medipole Grand Sud St Roch

Cabestany, , France

Site Status

CH de Cahors

Cahors, , France

Site Status

NephroCare

Castelnau-le-Lez, , France

Site Status

CH de Carcassonne

Cité de Carcassonne, , France

Site Status

AAIR Midi-Pyrénées

Colomiers, , France

Site Status

Centre Hospitalier Intercommunal du Val d'Ariège

Foix, , France

Site Status

Clinique du Pont de Chaume

Montauban, , France

Site Status

AIDER de Montpellier

Montpellier, , France

Site Status

CHRU de Montpellier - Hôpital Lapeyronie

Montpellier, , France

Site Status

Clinique de l'Occitanie

Muret, , France

Site Status

Polyclinique Le Languedoc

Narbonne, , France

Site Status

AIDER - Unité de Dialyse de Nîmes

Nîmes, , France

Site Status

CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, , France

Site Status

Gardialyse

Nîmes, , France

Site Status

CH de Perpignan - Hôpital Saint Jean

Perpignan, , France

Site Status

Centre Hospitalier Jacques Puel

Rodez, , France

Site Status

CH de Bigorre

Tarbes, , France

Site Status

CHRU de Toulouse - Hôpital de Rangueil

Toulouse, , France

Site Status

CHRU de Toulouse - Hôpital Larrey

Toulouse, , France

Site Status

CHRU de Toulouse - Hôptal Casselardit

Toulouse, , France

Site Status

Clinique Néphrologique Saint-Exupéry

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Dusseux E, Albano L, Fafin C, Hourmant M, Guerin O, Couchoud C, Moranne O. A simple clinical tool to inform the decision-making process to refer elderly incident dialysis patients for kidney transplant evaluation. Kidney Int. 2015 Jul;88(1):121-9. doi: 10.1038/ki.2015.25. Epub 2015 Feb 11.

Reference Type BACKGROUND
PMID: 25671769 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-A00464-47

Identifier Type: OTHER

Identifier Source: secondary_id

PHRC-I/2015/OM-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.